文献速递牙周病

列线图预测III或IV期牙周炎非手术治疗反应不佳

Nomogram predicting suboptimal nonsurgical therapy response in stage III or IV periodontitis using hematologic and periodontal indexes.
PubMed 文献 · J Am Dent Assoc · 2026-05-14

该回顾性研究纳入146例III或IV期牙周炎患者,构建列线图预测非手术治疗反应不佳。

要点

  • 厚龈生物型、C级牙周炎、血小板/淋巴细胞比值升高和平均红细胞血红蛋白是非手术治疗反应不佳的独立风险因素。
  • 列线图有助于早期识别非手术治疗反应不佳者,支持个性化干预。

核心结论

  • 厚龈生物型、牙周炎分级、血小板/淋巴细胞比值和平均红细胞血红蛋白是非手术治疗结局的显著预测因素。
  • 提出的列线图能够早期识别非手术治疗反应不佳者。

研究设计与样本

  • 回顾性研究,共纳入146例接受非手术牙周治疗的III或IV期牙周炎患者。
  • 数据集分为反应良好组(n=92)和反应不佳组(n=54)。

主要发现

  • 反应不佳定义为:6周随访时,初始探诊深度≥5mm的位点中≥30%未达到≥2mm的减少或临床健康。
  • 厚龈生物型、C级牙周炎、血小板/淋巴细胞比值升高和平均红细胞血红蛋白是反应不佳的显著风险因素。
  • 临床决策曲线分析证实预测模型在特定概率阈值内有用。

关键数值与推荐

  • 反应不佳标准:6周随访时,初始探诊深度≥5mm的位点中≥30%未达到≥2mm的减少或临床健康。

临床怎么用

  • 列线图支持个性化干预策略,以优化临床结局和资源利用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The authors aimed to identify risk factors for suboptimal response to nonsurgical periodontal therapy in patients with stage III or IV periodontitis and develop a predictive model to guide personalized treatment strategies. METHODS: A total of 146 patients with stage III or IV periodontitis who underwent nonsurgical periodontal treatment were retrospectively examined. Clinical and blood test data were collected. The data set was categorized into optimal (n = 92) and suboptimal (n = 54) response groups. Suboptimal responders were those with 30% or more of sites with initial probing depth of 5 mm or greater that failed to achieve a 2-mm or greater reduction or clinical health at the 6-week follow-up, and others were considered optimal. Results of logistic regression analyses identified independent risk factors, and a nomogram prediction model was constructed. Model discrimination was assessed using the area under the receiver operating characteristic curve and calibration was evaluated through the Hosmer-Lemeshow test and calibration curves. Clinical decision curve analysis was used to assess net benefit. RESULTS: Thick gingival phenotype, grade C periodontitis, elevated platelet to lymphocyte ratio, and mean corpuscular hemoglobin were significant risk factors for suboptimal response. The predictive model had strong discrimination (area under the receiver operating characteristic curve = 0.782) and good calibration (Hosmer-Lemeshow test, P = .532). Clinical decision analysis confirmed the usefulness of the predictive model within specific probability thresholds. CONCLUSIONS: Gingival phenotype, periodontitis grade, platelet to lymphocyte ratio, and mean corpuscular hemoglobin are significant predictors of nonsurgical treatment outcomes in stage III and stage IV periodontitis. The proposed nomogram enables early identification of suboptimal responders. PRACTICAL IMPLICATIONS: This nomogram supports personalized intervention strategies to optimize clinical outcomes and resource usage. This study was registered at the Chinese Clinical Trial Registry. The registration number is ChiCTR2400080731.

来源:J Am Dent Assoc,查看原文。版权归原作者所有。

引用

  1. Mu T, Yang Y, Li Z, et al. Nomogram predicting suboptimal nonsurgical therapy response in stage III or IV periodontitis using hematologic and periodontal indexes. J Am Dent Assoc. 2026. PMID: 42132709. doi:10.1016/j.adaj.2026.02.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。